Supraventricular tachycardia: Difference between revisions
No edit summary |
CSV import |
||
| Line 24: | Line 24: | ||
[[Category:Cardiac Arrhythmias]] | [[Category:Cardiac Arrhythmias]] | ||
[[Category:Clinical Medicine]] | [[Category:Clinical Medicine]] | ||
<gallery> | |||
File:SVT_Lead_II-2.JPG|ECG showing supraventricular tachycardia in Lead II | |||
File:SVT_overview_(CardioNetworks_ECGpedia).svg|Overview of supraventricular tachycardia | |||
File:SV_Tachycardia_marked.jpg|Marked supraventricular tachycardia | |||
File:SVT2012.JPG|Supraventricular tachycardia ECG | |||
File:A-fib.png|Atrial fibrillation | |||
File:Heart_conduct_sinus.gif|Heart conduction in sinus rhythm | |||
File:Heart_conduct_atrialfib.gif|Heart conduction in atrial fibrillation | |||
</gallery> | |||
Revision as of 11:10, 18 February 2025
Supraventricular tachycardia (SVT) represents a group of arrhythmias, or irregular heart rhythms, characterized by a heart rate exceeding the typical range and originating from cardiac tissue above the level of the ventricles. This means the abnormal rhythm arises either from the atria or the atrioventricular (AV) node.
Etiology and Pathophysiology
SVT typically results from faulty electrical activity in the heart. While several factors may contribute to its development, SVT commonly stems from a reentrant pathway, where the electrical impulses circularly move through the heart's conduction system, or an ectopic pacemaker, where a site other than the sinus node initiates the electrical signal.
Clinical Presentation
Symptoms of SVT can vary, ranging from almost unnoticed to debilitating. Common symptoms include palpitations, shortness of breath, chest discomfort, and light-headedness. In extreme cases, it can lead to unconsciousness or cardiac arrest, though this is rare.
Diagnosis
The primary tool for diagnosing SVT is an electrocardiogram (ECG), which records the electrical activity of the heart. In SVT, the ECG typically shows a rapid heart rate and narrow QRS complexes, but aberrant conduction or preexcitation may sometimes be present. Additional diagnostic tools can include Holter monitoring, exercise stress testing, and electrophysiological study.
Treatment and Management
The management of SVT aims at controlling the heart rate, preventing recurrences, and managing potential complications. Initial treatment options can include vagal maneuvers or medications that slow the heart rate such as beta-blockers or calcium channel blockers. In cases where these approaches are ineffective or if the patient has recurrent episodes, catheter ablation may be considered. This procedure targets and destroys the abnormal electrical pathways causing SVT.
See Also
References
|
|
|
-
ECG showing supraventricular tachycardia in Lead II
-
Overview of supraventricular tachycardia
-
Marked supraventricular tachycardia
-
Supraventricular tachycardia ECG
-
Atrial fibrillation
-
Heart conduction in sinus rhythm
-
Heart conduction in atrial fibrillation

